Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation (Narrative) (Details)

v3.22.4
Basis of Presentation (Narrative) (Details)
3 Months Ended
Dec. 31, 2022
item
Basis of Presentation [Abstract]  
Number of FDA approved products 2